Cargando…
Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759471/ https://www.ncbi.nlm.nih.gov/pubmed/34348106 http://dx.doi.org/10.1016/j.ijrobp.2021.04.048 |
_version_ | 1784852239912796160 |
---|---|
author | Baumann, Brian C. Sargos, Paul Efstathiou, Jason A. |
author_facet | Baumann, Brian C. Sargos, Paul Efstathiou, Jason A. |
author_sort | Baumann, Brian C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9759471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97594712022-12-19 Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain Baumann, Brian C. Sargos, Paul Efstathiou, Jason A. Int J Radiat Oncol Biol Phys Editorial Published by Elsevier Inc. 2021-09-01 2021-08-01 /pmc/articles/PMC9759471/ /pubmed/34348106 http://dx.doi.org/10.1016/j.ijrobp.2021.04.048 Text en © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Baumann, Brian C. Sargos, Paul Efstathiou, Jason A. Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain |
title | Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain |
title_full | Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain |
title_fullStr | Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain |
title_full_unstemmed | Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain |
title_short | Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain |
title_sort | standard versus hypofractionated radiation therapy for bladder cancer: new insights, but questions remain |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759471/ https://www.ncbi.nlm.nih.gov/pubmed/34348106 http://dx.doi.org/10.1016/j.ijrobp.2021.04.048 |
work_keys_str_mv | AT baumannbrianc standardversushypofractionatedradiationtherapyforbladdercancernewinsightsbutquestionsremain AT sargospaul standardversushypofractionatedradiationtherapyforbladdercancernewinsightsbutquestionsremain AT efstathioujasona standardversushypofractionatedradiationtherapyforbladdercancernewinsightsbutquestionsremain |